WHO ICTRP trial
To explore the treatment of psoriasis with sleep disorder by cooling blood and…
ChiCTR2100050632 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2100050632 |
|---|---|
| Public title | To explore the treatment of psoriasis with sleep disorder by cooling blood and calming nerves: a randomized controlled trial |
| Scientific title | Study on the effect of melatonin regulating oxidative stress in the treatment of psoriasis with sleep disorder |
| Primary sponsor | Dongzhimen Hospital affiliated to Beijing University of Chinese Medicine |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Phase | 0 |
| Countries | China |
| Conditions | Psoriasis |
| Interventions | Experiment group1:Oral Xiaoyin Anshen Decoction;Experiment group2:Oral Liangxue Jiedu Decoction;Experiment group3:Oral Qingxin Anshen Decoction;Control group:Oral compound Qingdai capsule |
| Registration date | Sep 1, 2021 |
| Target size | Experiment group1:30;Experiment group2:30;Experiment group3:30;Control group:30 |
| Secondary IDs | ChiMCTR2100005257 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: